In accordance with the 'Drug Permit Change Order' (Drug Safety Evaluation Division-No. 2293, effective date April 21, 2017), the precautions for use of Amoctin Tablet 375 mg have been changed.


For further details, please refer to the ‘Product Introduction’ section and attached documents.